An investigation on behalf of current long term investors in NewLink Genetics Corp (NASDAQ:NLNK) shares over possible breaches of fiduciary duty by certain officers and directors was announced and NASDAQ:NLNK stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 01/16/2017 --An investigation was announced on behalf of investors in shares of NewLink Genetics Corp (NASDAQ:NLNK) over possible breaches of fiduciary duties by certain directors of NewLink Genetics Corp.

Investors who are current long term investors in NewLink Genetics Corp (NASDAQ:NLNK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm for current long term investors in NASDAQ:NLNK stocks follows a lawsuit pending against NewLink Genetics over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ:NLNK stocks, concerns whether certain NewLink Genetics directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose thatthe Company's algenpantucel-L treatment was ineffective and potentially harmful to patients, and that as a result of the foregoing, NewLink's public statements were materially false and misleading at all relevant times.

On May 09, 2016, NewLink Genetics Corp (NASDAQ:NLNK) announced the results of its Phase 3 clinical trial for algenpantucel-L for patients with resected pancreatic cancer. NewLink Genetics Corp said that the IMPRESS Phase 3 study of algenpantucel-L for patients with resected pancreatic cancer did not achieve its primary endpoint. Shares of NewLink Genetics Corp (NASDAQ:NLNK) declined from $54.24 per share in September 2015 to as low as $9.23 per share on May 12, 2016.

Those who purchased shares of NewLink Genetics Corp have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com